The replication of mumps virus was studied in human continuous lymphoblastoid cell lines (LCLs) with T or B characteristics and in lymphocyte subpopulations derived from peripheral blood. T-LCLs supported effective virus replication as shown by high titers of free and cell-associated virus over 1 to 4 days after infection. By immunofluorescence analysis, the majority of cells were positive for mumps virus antigens. In contrast, the B-cell lines produced low titers of infectious virus, and only a small percentage expressed viral antigens. This resistance of the B-LCLs was found with several mumps virus strains. Cultures of peripheral blood mononuclear cells also supported mumps virus replication. Very high titers of infectious virus (108 PFU/ml) were observed in cultures prestimulated with phytohaemagglutinin. Studies with enriched T and B cells point to the activated T lymphocyte as the major virus-producing cell.
The replication of mumps virus was studied in human continuous lymphoblastoid cell lines (LCLs) with T or B characteristics and in lymphocyte subpopulations derived from peripheral blood. T-LCLs supported effective virus replication as shown by high titers of free and cell-associated virus over 1 to 4 days after infection. By immunofluorescence analysis, the majority of cells were positive for mumps virus antigens. In contrast, the B-cell lines produced low titers of infectious virus, and only a small percentage expressed viral antigens. This resistance of the B-LCLs was found with several mumps virus strains. Cultures of peripheral blood mononuclear cells also supported mumps virus replication. Very high titers of infectious virus (108 PFU/ml) were observed in cultures prestimulated with phytohaemagglutinin. Studies with enriched T and B cells point to the activated T lymphocyte as the major virus-producing cell.
Mumps virus infections differ widely in the severity of clinical manifestations. Although restricted to the parotid glands in the majority of cases, complications such as meningitis, encephalitis, pancreatitis, or orchitis are not infrequently observed. Moreover, mumps virus has also been implicated as one of the etiological agents of juvenile-onset diabetes meUitus. Our knowledge about the pathogenesis of mumps and its complications is stil limited. We do not know whether the various disease manifestations are due to either different biological properties of the infecting viruses or individual variations of the host's defense mechanisms or both. There is also the possibility that in some instances mumps virus interferes with the immune system itself, since many viruses have been shown to infect and to replicate in immunocompetent cells (4, 5, 17, 23, 25) . Such , and T-ALL (15 Antisera. Unlabeled and fluorescein-conjugated guinea pig and goat antimumps antibodies were purchased from Microbiological Associates, Bethesda, Md. Specific antisera were also prepared by immunizing rabbits with purified mumps virus (Enders eggadapted strain) grown in 8-day-old embryonated eggs for 4 days at 35°C and purified from the allantoic fluid as described by Huppertz et al. (9) . Rabbits were primed with 100 ,ug of virus in Freund complete adjuvant, boostered twice with 10 p.g in phosphatebuffered saline at 2-week intervals, and bled 10 days after the last boost. The complement-fixing and neutralizing titers of the serum samples used were 1:1,024 and 1:128, respectively. Tetramethylrhodamine-labeled rabbit antibodies against human IgM, IgG, and IgA were purchased from DAKO Corp., Copenhagen, Denmark.
Virus Infection of lymphoid cells. Cells (5 x 106/ml) in serum-free medium RPMI 1640 were exposed in suspension to mumps virus at multiplicities of infection (MOI) ranging from 0.01 to 10 for 60 min at 37°C. The cells were washed once with RPMI 1640 and then incubated in 1.0 ml of a 1:10 dilution of the rabbit antimumps hyperimmune serum for 30 min at 37°C to neutralize nonadsorbed virus. The cells were washed three times again and cultured in 24-well cluster plates (Costar; Cambridge, Mass.) at a concentration of 2 x 105 to 5 x 105 cells/ml for LCLs or 2 x 106 cells/ml for PBMC.
Virus plaque assay. Titers of infectious virus were determined by a standard plaque-forming assay on Vero cells. Virus-containing supernatants were 10-fold serially diluted, and 0.5 ml of each dilution was added in duplicate to Vero cell monolayers in 30-mm petri dishes (Greiner, Nurtingen, Federal Republic of Germany). The difference in virus plaques between replicate cultures was usually less than 10%o.
For the detection of cell-associated virus, infected cells were frozen and thawed three times in 0.5 ml of phosphate-buffered saline. Vero cells were infected for 60 min at 37°C and then overlaid with minimal essential medium containing 2% heat-inactivated fetal calf serum and 0.75% agar (Bacto agar; Difco). Plaques were read after 4 to 6 days after staining the cell sheets with neutral red.
Infectious center assay. The efficiency of infection of peripheral blood lymphocyte subpopulations was determined by infectious center assays as described by Bloom et al. (1) . Infection of cells and treatment with hyperimmune serum were performed as described above. Infected cells were diluted 10-fold, ranging from 102 to 106 cells/ml in minimal essential medium containing 0.1% agar. Samples of 100 p.l were plated in triplicate on Vero cell monolayers in 30-mm petri dishes and incubated for 60 min at 37°C in a humidified atmosphere and then overlaid with medium containing 0.75% agar. Plaques were read after 5 days. The results are expressed as virus plaque-forming cells (V-PFC) per 102 cells.
Immunofluorescence studies. For detecting intracytoplasmic viral antigens, air-dried cell smears were fixed for 10 min in acetone and then stained with fluorescein-conjugated mumps virus-specific antibodies. After staining, slides were extensively washed in phosphate-buffered saline and finally mounted in buffered glycerol. In some experiments, air-dried cell smears were fixed with methanol and stained first with fluorescein-labeled goat antimumps antibodies followed by the rhodamine-labeled rabbit anti-human immunoglobulin reagent. Methanol was found to be superior to acetone or ethanol in preserving both immunoglobulins and viral antigens. Slides were examined by using a Leitz microscope with fluorescence epi-illumination and selective filter systems for discrimination of rhodamine and fluorescein. At least 200 cells were counted.
RESULTS
Infectious mumps virus titers in T and B lymphoblastoid cells. A variety of human lymphoblastoid cell lines with either T-or B-cell characteristics were infected with a fresh mumps virus isolate (strain HA-98720) (Fig. 1) Comparison of different mumps virus strain. As most experiments were carried out with a fresh mumps virus isolate (HA-98720), four different mumps virus strains were also tested for their ability to replicate in lymphoblastoid cells with T-or B-cell characteristics. In an experiment using MOLT-4 and U 698 M cells as representative cell lines, all virus strains preferentially replicated in MOLT-4 cells ( Table 2) . This preference was more pronounced with fresh mumps virus isolates. However, the higher affinity for the T-LCL was also observed with the high-passage Enders laboratory strain and the attenuated Jeryl-Lynn vaccine strain.
Mumps virus replication in PBMC. In subsequent studies, experiments were performed to 
Susceptibility of activated T and B lymphocytes
to mumps virus infection. The following protocol was used to obtain enriched fractions of activated T and B cells. Freshly isolated PBMC were subjected to polyclonal stimulation by PWM for 24 h, whereafter the nonadherent (monocytedepleted) cells were separated by E-rosetting and subsequent gradient centrifugation. The Tcell-enriched and T-cell-depleted fractions were infected with mumps virus at an MOI of 10.
Infectious center assays were performed to determine whether infectious virus was being synthesized in each of these cell populations. An enrichment for T cells was paralleled by a significant increase in V-PFC (Table 3) . When these cells were cultured for an additional period of 5 days, plasmacytes were found only in T-cell-depleted, B-cell-enriched populations (Table 4) . Moreover, after double staining of such cells with fluorescein-coupled antimumps and rhodamine-conjugated anti-human immunoglobulin reagents, mumps viral antigens were detected only in a small fraction (3% out of 26%) of immunoglobulin-synthesizing B cells. The mumps virus-positive, immunoglobulinnegative cells still present in the T-cell-depleted fraction had a blastlike appearance similar to that of the cells in the T-cell-enriched fraction. 
DISCUSSION
The results presented here show that mumps virus is lymphotropic. This observation was made by using five different mumps viruses, including three low-passage mumps virus isolates, a high-passage laboratory strain (Enders), and an attenuated vaccine strain (Jeryl-Lynn). All of these viruses could replicate in human LCLs and human PBMC. The findings with human PBMC are in agreement with earlier observations by Duc-Nguyen and Henle (6) and by Willems et al. (24) . These authors found that cultured leukocytes in the presence of PHA were capable of supporting synthesis of mumps viral antigens.
In addition, mumps virus appears to replicate preferentially in lymphoid cells with T-cell characteristics. The replication in cultures of T-cell lines (MOLT-4, T-ALL, and JM) was very efficient, as the majority of cells became infected and high amounts of infectious virus were produced over 2 to 4 days of infection. The observed resistance of the B-cell lines (Raji, U 698 M, and BJAB) was not an absolute one, since low titers of newly synthesized infectious virus were found in B-LCL cultures. Furthermore, after infection at high MOIs, 10 Since lymphoblastoid cell lines might differ to some extent from their original progenitor cells, it was important to establish the validity of this observation also for native human blood lymphocytes. The selective tropism of mumps virus for activated human blood T cells is suggested by three lines of evidence. (i) A strong enhancement of infectious virus production was observed in cultures prestimulated with PHA, a Tcell mitogen. In fact, the PHA-activated T lymphocyte is the most efficient target cell for growing high titers of mumps virus, much more efficient than Vero cells or human fibroblasts (B. virus-positive, immunoglobulin-negative cells probably represents residual T cells still present in the T-cell-depleted fraction. All of these data together indicate that the relative resistance of B cells and the high permissiveness of T cells to mumps virus infections apply both to LCL cells and native human lymphocytes. Thus, mumps virus seems to belong to the group of viruses that selectively replicate in T cells such as vesicular stomatitis virus (2, 5) and rubella virus (4) . In this aspect, mumps virus markedly differs from measles (10, 22) and herpes simplex virus (20) , as both viruses are not restricted to lymphoid cells of either T-or B-cell origin.
No effort was made in this study to exclude the possibility that mumps virus may also be replicating in null cells or monocytes. However, preliminary data from our laboratory show that the contribution of these cells to total virus production by human PBMC is only minimal.
The high affinity of mumps virus for T lymphocytes and the efficient replication in these cells is an indication that T lymphocytes could be a natural target for mumps virus infection in vivo. The interaction of the virus with T lymphocytes might play a major role in the pathogenesis of the disease and its complications. First, in vivo mumps virus could initially replicate in the T-cell-dependent lymphoid areas adjacent to the respiratory tract, and the spread of virus to other sites of the body, including the central nervous system, could be facilitated by migrating virusinfected T lymphocytes. Persistence in small resting lymphocytes similar to measles virus (10, 13) might also be a possibility. In fact, there is preliminary evidence from this laboratory that mumps virus in vitro readily establishes persistent virus infections in T-LCLs. In vitro, mumps virus has also a marked cytopathogenic effect as shown by higher rates of degenerating cells in virus-infected than in mock-infected cell populations. The various mumps complications could therefore be due to selective infection and destruction of specific effector or immunoregulatory T cells. In an experimental system, mumps virus has already been shown to cause depression of delayed-type hypersensitivity (8) . This observation was also made in humans after vaccinations with live attenuated mumps virus (12) . The precise mechanisms underlying mumps virus-induced immunosuppression are currently under investigation in our laboratory.
